Skip to content

To study efficacy of medicated enema and Satyadi decoction in the management of Rheumatoid Arthritis disease.

Comparative study of Vaitarana basti and Satyadi Kwath in Management of Amavata (Rheumatoid Arthritis) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086032
Enrollment
60
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

Dr Mitali kurmi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who will fulfill the revise 1.Criteria for RA fixed by American college of rheumatology in 2010. 2.Patients of RA having chronicity of less than 10 yrs. 3. RA factor positive and negative both case will be included.

Exclusion criteria

Exclusion criteria: 1.Chronicity of more than 10 yrs will be excluded. 2.Having severe deformity. 3.Patients having Cardiac disease, Pulmonary TB ,Pregnancy. 4.Complicated Diabetes mallitus. 5.Malignancy 6.Ankylosing Spondylitis 7.Arthritis due to other cause like psoriatic arthritis etc

Design outcomes

Primary

MeasureTime frame
1.To evaluate the efficacy of Satyadi Kwath in the management of Amavata. 2.To evaluate the efficacy of vaitaran vasti in the management of Amavata. 3.To evaluate the combined efficacy of Satyadi kwath and Vaitaran vasti in the management of Amavata.Timepoint: 30,60 and 90 days.

Secondary

MeasureTime frame
To asses the improvement after treatment.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Ranjan Kumar Kalita

Govt Ayurvedic college and Hospital Guwahati

rkslavia1972@gmail.com8638211399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026